Progressive MS as the open question
Therapy for relapsing MS is mature; primary and secondary progressive disease remains the unsolved problem.
Relapsing MS has effective, well-characterised therapy. Progressive MS - both primary and secondary - is where the unmet need still sits, and where new mechanism classes are being tested. The reading on whether any of them break through is what we are watching.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
- ExplainedWhat is spasticity?
- SnapshotAcute ischemic stroke therapy reference (2026)
- ExplainedAcute ischemic stroke explained
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.